Organization · Accelerator
Australian Stroke and Heart Research Accelerator (ASHRA)
The Australian Stroke and Heart Research Accelerator (ASHRA) is a collaborative initiative focused on enhancing cardiovascular research in Australia. It aims to accelerate the translation and commercialization of research to improve health outcomes.
Overview
What Australian Stroke and Heart Research Accelerator (ASHRA) does
What Australian Stroke and Heart Research Accelerator (ASHRA) is
The Australian Stroke and Heart Research Accelerator (ASHRA) is a collaborative initiative focused on enhancing cardiovascular research in Australia. It aims to accelerate the translation and commercialization of research to improve health outcomes.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 5, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find Australian Stroke and Heart Research Accelerator (ASHRA) elsewhere
Open the official website or a supported primary organization account.
Capability profile
Australian Stroke and Heart Research Accelerator (ASHRA) as a funder
Investment thesis
ASHRA aims to accelerate the translation and commercialization of cardiovascular research to improve health outcomes and reduce health inequities associated with cardiovascular disease.
Focus narrative
ASHRA focuses on cardiovascular research, specifically targeting heart failure, coronary artery disease (CAD), multiple cardiovascular diseases (CVD), and stroke. The organization manages a research portfolio that includes 22 projects across various innovations, including therapeutic solutions, medical devices, digital health, screening methods, and cohort registers.
Focus and fit
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 22
Portfolio context
ASHRA's research portfolio includes 22 projects addressing various cardiovascular diseases. Innovations are categorized into 6 therapeutic solutions, 8 devices, 4 digital health initiatives, 3 screening methods, and 1 cohort register.
Capability profile
Australian Stroke and Heart Research Accelerator (ASHRA) as a program host
Program thesis
ASHRA accelerates the translation of cardiovascular research into practical solutions to combat heart disease and stroke, addressing health inequities in the process.
Focus narrative
ASHRA's primary focus is on cardiovascular research, specifically targeting heart failure, coronary artery disease (CAD), multiple cardiovascular diseases (CVD), and stroke. The organization manages a comprehensive research portfolio that includes 22 projects across various innovations, including therapeutic solutions, medical devices, digital health, screening methods, and cohort registers.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator
- Sectors
- Healthcare
- Regions
- Australia
Common questions
What to know about Australian Stroke and Heart Research Accelerator (ASHRA)
Upseed classifies Australian Stroke and Heart Research Accelerator (ASHRA) under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.